Market Leader ZoomRx serves 19 of the top 20 global pharma partners and over 100 firms, with a 100% client renewal rate, indicating strong credibility and a premium opportunity to upsell additional services such as AI-enhanced market strategy, research execution, and ongoing performance tracking.

AI First The firm emphasizes AI-enabled insights that amplify human expertise and offers products like Sagan Agents and Ferma Engine, presenting cross-sell opportunities around AI operating systems, agent-based workflow automation, and custom AI solutions for drug development and commercialization.

Data Scale With 700M+ benchmark datapoints and a 60k+ healthcare professional panel, there is a clear opportunity to offer expanded data-driven services, including benchmarking, real-world evidence generation, competitive intelligence, and market access analytics for broader portfolio strategies.

Expansion Momentum Recent acquisitions and product launches (Vivisum Partners acquisition; ZoomRx TV Tracking; Ferma Engine; Sagan Agents) signal capability and appetite for expanding consultative offerings, enabling cross-sell of brand building, TV/media measurement, and customized AI solutions.

Global Capacity 450+ life sciences consultants worldwide and substantial enterprise client base suggest capacity to scale multi-region market access programs, global launch support, and region-specific competitive intelligence for multinational pharma and biotech brands.